OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Update

OrthoPediatrics Corp. (NASDAQ:KIDSGet Free Report) was the target of a large decrease in short interest in June. As of June 15th, there was short interest totalling 1,040,000 shares, a decrease of 5.5% from the May 31st total of 1,100,000 shares. Currently, 6.5% of the company’s stock are sold short. Based on an average daily trading volume, of 143,700 shares, the days-to-cover ratio is presently 7.2 days.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on KIDS shares. Needham & Company LLC increased their price target on OrthoPediatrics from $37.00 to $42.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. Truist Financial raised their price objective on OrthoPediatrics from $35.00 to $38.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a research report on Tuesday, May 7th.

View Our Latest Stock Report on OrthoPediatrics

Institutional Investors Weigh In On OrthoPediatrics

Institutional investors have recently added to or reduced their stakes in the business. Millrace Asset Group Inc. acquired a new stake in OrthoPediatrics in the fourth quarter worth about $1,283,000. Brown Advisory Inc. raised its stake in shares of OrthoPediatrics by 1.6% in the fourth quarter. Brown Advisory Inc. now owns 1,628,779 shares of the company’s stock worth $52,952,000 after purchasing an additional 25,337 shares during the last quarter. Prime Capital Investment Advisors LLC purchased a new position in shares of OrthoPediatrics in the fourth quarter worth about $2,035,000. Braidwell LP raised its stake in shares of OrthoPediatrics by 4.7% in the fourth quarter. Braidwell LP now owns 1,107,770 shares of the company’s stock worth $36,014,000 after purchasing an additional 50,000 shares during the last quarter. Finally, Wasatch Advisors LP raised its stake in shares of OrthoPediatrics by 6.7% in the fourth quarter. Wasatch Advisors LP now owns 413,653 shares of the company’s stock worth $13,448,000 after purchasing an additional 26,073 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Trading Up 3.2 %

Shares of KIDS stock opened at $29.10 on Wednesday. OrthoPediatrics has a 1-year low of $23.10 and a 1-year high of $45.96. The stock’s 50-day moving average is $31.01 and its 200 day moving average is $29.67. The company has a quick ratio of 1.99, a current ratio of 4.45 and a debt-to-equity ratio of 0.03.

OrthoPediatrics (NASDAQ:KIDSGet Free Report) last issued its quarterly earnings results on Monday, May 6th. The company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.42) by $0.12. The business had revenue of $44.69 million during the quarter, compared to the consensus estimate of $41.63 million. OrthoPediatrics had a negative return on equity of 5.12% and a negative net margin of 13.58%. As a group, equities analysts anticipate that OrthoPediatrics will post -1.2 EPS for the current fiscal year.

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Stories

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.